Ledger.Open graph →
SEC Form D · filed August 10, 2017

Homology Medicines, Inc

Offering
$83.5M
Sold
$83.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BEDFORD, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Kush Parmar · Boston, MADirectorBrad Smith · Southfield, MIExecRichard Gregory · Boston, MADirectorMahendra Shah · Middlesex, United KingdomDirectorCameron Wheeler · Seattle, WADirectorArthur Tzianabos · Santa Monica, CAExec · DirectorSiyamak Rasty · Bedford, MAExecKush Parmar · San Francisco, CADirectorBrad Smith · Nashville, TNExecRichard Gregory · Boston, MADirectorMahendra Shah · Palo Alto, CADirectorCameron Wheeler · Seattle, WADirectorArthur Tzianabos · Bedford, MAExec · DirectorSiyamak Rasty · Bedford, MAExecAlbert Seymour · Bedford, MAExecSteven Gillis · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Homology Medicines, Inc. — SEC Form D filing (2017) | Ledger